Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-016857

Chief Medical Officer sold 7,092 shares at an average $66.38 ($470,741)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2021-03-01 Sale −1,327 $64.54 $85,646 170,906 I
Ho Carole Chief Medical Officer 2021-03-01 Sale −2,871 $65.74 $188,725 168,035 I
Ho Carole Chief Medical Officer 2021-03-01 Sale −1,173 $67.07 $78,670 166,862 I
Ho Carole Chief Medical Officer 2021-03-01 Sale −1,320 $68.01 $89,772 165,542 I
Ho Carole Chief Medical Officer 2021-03-01 Sale −208 $68.87 $14,324 165,334 I
Ho Carole Chief Medical Officer 2021-03-01 Sale −125 $70.07 $8,758 165,209 I
Ho Carole Chief Medical Officer 2021-03-01 Sale −68 $71.27 $4,846 165,141 I
Open-market sales · 7,092 sh · avg $66.38 · $470,741
Loading xslF345X03/doc4.xml…